Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IP Group PLC Director's Dealing 2023

May 10, 2023

4852_dirs_2023-05-10_c9800457-c826-408d-be1e-0ae7e50d0d4e.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 9756Y

IP Group PLC

10 May 2023

FOR RELEASE ON 10 May 2023

IP Group - Director/PDMR share purchases

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, has been notified that on 5 May 2023, Christopher Glasson, Finance Director and a PDMR, purchased a total of 49,690 Shares of 2p each as outlined in the table below.

Name Number of shares acquired Price per share Resulting beneficial interest
Christopher Glasson 49,690 55.12p 204,013

The notification below, made in accordance with the requirements of article 19 of the UK Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Christopher Glasson

2

Reason for the notification

a)

Position/status

Finance Director (PDMR)

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

LEI

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

ISIN: GB00B128J450

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
35,882

13,808
55.15p

55.05p

d)

Aggregated information

-     Aggregated volume

-     Price

49,690

55.12 pence per share

e)

Date of the transaction

5 May 2023

f)

Place of the transaction

London Stock Exchange, Main Market

For more information, please contact:

IP Group plc www.ipgroupplc.com
Greg Smith, Chief Executive Officer

David Baynes, Chief Financial and Operating Officer

Liz Vaughan-Adams, Communications
+44 (0) 20 7444 0050

+44 (0) 20 7444 0062/+44 (0) 7967 312125
Portland
Vic Wallin

Alex Donaldson
+44 (0) 7973 823119

+44 (0) 7516 729702

Notes for editors

About IP Group

IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science investor, we develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

For more information, please visit our website at www.ipgroupplc.com.

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGPUBUAUPWGGU